Evolution Wealth Management’s Biogen BIIB Stock Holding History

Evolution Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8	Closed	-$1K	–	601
2025 Q2	$1K	Buy	+8	New	+$997	﹤0.01%	540

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Evolution Wealth Management's BIIB Position: Q3 2025 in Review

Evolution Wealth Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 8 shares — an estimated $1K sold.

Evolution Wealth Management first reported a position in BIIB in Q2 2025 and held it in 1 quarter. The position peaked at $1K in Q2 2025. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

Evolution Wealth Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
Evolution Wealth Management sold 8 Biogen shares in Q3 2025, an estimated $1K.
Evolution Wealth Management first reported a position in Biogen in Q2 2025 and held it in 1 quarter.
Evolution Wealth Management's Biogen position peaked at $1K in Q2 2025.
905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Evolution Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.